Showing results (31-40 of 164) with videos related to
Sort By:
Pageof 17
Neuroscience Letters|February 15, 1988
Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmissionM Savasta, A Dubois, J Benavidès, et al.Journal of Neuroscience Research|October 15, 1994
Normal distribution of alpha 2-adrenoceptors in the rat spinal cord and its modification after noradrenergic denervation: a quantitative autoradiographic studyC Roudet, P Mouchet, C Feuerstein, et al.La Revue De Medecine Interne|February 28, 2002
[New Level III opioids of the World Health Organization]G Laval, B Sang, M Mallaret, et al.Therapie|March 1, 1996
[Macrolides and drug interactions: review of the literature]V Lauby, M Mallaret, I Dufrêne, et al.La Revue De Medecine Interne|January 1, 1995
[Neuropsychic side-effects of therapeutic doses of zipeprol]]V Lauby, B Imbert, H Eysseric, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 17, 1999
[Mathematical model of micturition allowing a detailed analysis of free urine flowmetry]F Valentini, G Besson, P NelsonNeuroscience|January 1, 1989
The colocalization of cholecystokinin and tyrosine hydroxylase mRNAs in mesencephalic dopaminergic neurons in the rat brain examined by in situ hybridizationM Savasta, E Ruberte, J M Palacios, et al.Revue Neurologique|October 21, 1999
[Role of emergency cerebrovascular units in the network of care]M Hommel, A Jaillard, G BessonCerebrovascular Diseases (Basel, Switzerland)|September 6, 2000
Risk factors for lacunar infarctsG Besson, M Hommel, J PerretLa Revue De Medecine Interne|January 8, 2011
[Efficacy of replacement enzyme therapy on central nervous system manifestations in Fabry's disease]G Besson, W Vadot, J GuellerinPageof 17